Anteris Technologies Global Corp. (AVR) Stock Price & Analysis

Anteris Technologies Global Corp. (AVR) closed at USD 6.36 on Thursday, October 15, 2026, up 1.60% on the day. The US market is currently closed; this is not a live price.

The prior close was USD 6.26; the Oct 15, 2026 session ranged USD 6.12–6.38 on volume of 825,617 shares. Market capitalization is $619.84M, with a 52-week range of USD 3.3–11.06 (NGM). Source: Nexqual, retrieved October 16, 2026 at 05:20 UTC.

Also available as compact Markdown for AI agents: nexqual.com/AVR.md

Key facts (AVR)

Analysts (AVR)

Consensus Buy (mean 2.20 on a 1–5 scale), 5 analysts; mean target USD 14 (low 10, high 16).

Rating changes, last 120 days:

DateFirmActionRatingPrice target
2026-10-14Cantor FitzgeraldReiteratedOverweight$15
2026-10-07BarclaysInitiatedEqual-Weight$10
2026-08-14Cantor FitzgeraldReiteratedOverweight$15

Total return (dividends reinvested) (AVR)

1Y (from 2025-10-16)5Y (from 2024-12-09)
Total return+28.2%+13.6%
S&P 500 (SPY)+18.1%+85.1%
Per year+28.3%+7.1%
Volatility (annualized)66.7%89.9%
Max drawdown-46.8% (Oct 2025→Nov 2025)-70.1% (Feb 2025→Apr 2025)

Key Statistics (as of October 16, 2026 at 05:20 UTC)

PriceUSD 6.36
Change▲ 1.60% (up)
Previous CloseUSD 6.26
OpenUSD 6.26
Day RangeUSD 6.12 – 6.38
52-Week RangeUSD 3.3 – 11.06
Volume825,617 shares
Market Cap$619.84M
ExchangeNGM

Technical Analysis (AVR)

Nexqual's technical model rates AVR "SELL" based on 2 bullish and 5 bearish signals across 127 daily candles, as of October 16, 2026 at 05:20 UTC.

Overall SignalSELL
RSI (14)26.16 (oversold)
vs SMA50Below (USD 8.23)
MACD-0.53 (negative)

Analyst Ratings (AVR)

Wall Street analysts rate AVR "Buy" based on 5 analysts, with a mean price target of USD 14 (range USD 10–16), per Nexqual as of October 16, 2026 at 05:20 UTC.

Consensus RatingBuy
Analyst Count5
Mean TargetUSD 14
High TargetUSD 16
Low TargetUSD 10
Buy / Hold / Sell4 / 1 / 0

Earnings (AVR)

Next Earnings Date2026-11-12
EPS EstimateUSD -0.31
Revenue Estimate$3.90M

Recent Earnings History

QuarterActual vs Estimate
2026-06-30USD -0.3 vs est -0.21 ▼ miss
2025-12-31USD -0.75 vs est -0.56 ▼ miss
2025-09-30USD -0.62 vs est -0.58 ▼ miss

Source: Nexqual, October 16, 2026 at 05:20 UTC.

Financials & Fundamentals (AVR)

Total Revenue$2.24M
Revenue Growth (latest quarter, YoY)+63.30%
Gross Margin+74.98%
Operating Margin-3072.05%
Profit Margin+0.00%
ROE-74.65%
Debt / Equity0.01
Current Ratio14.2
Total Cash$256.87M
Total Debt$3.32M

Source: Nexqual, October 16, 2026 at 05:20 UTC.

Financial Health Score (AVR)

Nexqual rates Anteris Technologies Global Corp.'s overall financial health "Weak" across five dimensions, as of October 16, 2026 at 05:20 UTC.

GrowthCritical — Revenue -37% YoY (annual), sharp decline
ProfitabilityCritical — Heavily loss-making — early-stage company
Balance SheetStrong — $257M cash vs $3M debt, net cash position
Cash FlowWeak — Operating cash flow -$86M (TTM)
EfficiencyCritical — ROE -75%, ROA -42.5%

Ownership (AVR)

Insider Ownership+16.48%
Institutional Ownership+71.88%
Shares Outstanding97.46M
Float65.99M
Short % of Float+9.78%

Source: Nexqual, October 16, 2026 at 05:20 UTC.

Leadership (AVR)

Anteris Technologies Global Corp. is led by Wayne Geoffrey Paterson (age 58), Vice Chairman & CEO, per Nexqual as of October 16, 2026 at 05:20 UTC.

Vice Chairman & CEOWayne Geoffrey Paterson (age 58)
President & DirectorDavid St. Denis (age 56)
Chief Financial OfficerBrent A. Moen (age 58)

Major Backers & Investors (AVR)

Notable institutional backers of Anteris Technologies Global Corp. include L1 Capital Pty Ltd, FMR, LLC, Fidelity, according to Nexqual as of October 16, 2026 at 05:20 UTC.

Active Investors

InvestorStake
L1 Capital Pty Ltd7.99%
FMR, LLC7.05%
Fidelity7.01%
Sio Capital Management, LLC5.69%
Perceptive Advisors Llc3.51%
Nantahala Capital Management, LLC3.47%
Adar1 Capital Management, LLC 3.23%
RA Capital Management, L.P.3.08%

Index Funds (Passive)

FundStake
BlackRock8.86%

Source: Nexqual, October 16, 2026 at 05:20 UTC.

Peers & Related Stocks

SymbolNamePriceChange
ESTAEstablishment Labs Holdings IncUSD 61.36▲ 4.98%
ALMRAlamar Biosciences, Inc.USD 27.42▲ 16.58%
INSPInspire Medical Systems, Inc.USD 70.12▲ 1.83%
BFLYButterfly Network, Inc.USD 7.85▼ 3.09%
AXGNAxoGen, Inc.USD 35.63▼ 1.49%
UFPTUFP Technologies, Inc.USD 297.19▲ 0.99%

Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 16, 2026 at 05:20 UTC. This page is informational and not investment advice.

For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt